Results 281 to 290 of about 4,346,534 (345)
Some of the next articles are maybe not open access.

Blood Screening for HBV DNA

Journal of Clinical Virology, 2006
The safety of the blood supply has been greatly improved in the past two decades owing to continuous improvement in the technology and sensitivity of laboratory testing, better donor education and selection, and tighter quality control on blood bank operations.
openaire   +2 more sources

Studies on the structure of HBV DNA.

Science in China. Series B, Chemistry, life sciences & earth sciences, 1989
The structure of HBV adr NC-1 DNA is analyzed and compared with another five strains of HBV DNAs. Some of the prokaryotic promoter-like sequences, palindrom sequences and ATAA are found. An enhancer core sequence and some other characteristics are also shown.
Qi, ZH, Yan, J, Zhu, QL
openaire   +3 more sources

Assessment of a method for detecting serum HBV DNA with HBV DNA probe labelled directly by alkaline phosphatase.

Hepatobiliary & pancreatic diseases international : HBPD INT, 2004
To assess a sensitive and specific technique for detecting serum HBV DNA with an HBV DNA probe labelled directly by alkaline phosphatase (AlkPhos Direc probe).AlkPhos Direc probe was prepared with purified HBV DNA labelled directly by alkaline phosphatase. The probe and chemiluminescent substrate CDP-star for AP were used in hybridization assay.
Ya-Xi, Chen   +4 more
openaire   +2 more sources

An overview of assays for serum HBV DNA.

Clinical laboratory, 2001
link_to_subscribed_fulltext
Ho, SKN, Chan, TM
openaire   +2 more sources

Residual HBV DNA and pgRNA viraemia is associated with hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy

Journal of gastroenterology, 2021
Lung-Yi Mak   +10 more
semanticscholar   +1 more source

State of HBV DNA in HBsAg‐negative, anti‐HCV‐positive hepatocellular carcinoma: Existence of HBV DNA possibly as nonintegrated form with analysis by Alu‐HBV DNA PCR and conventional HBV PCR

Journal of Medical Virology, 2001
AbstractThe role of hepatitis B virus (HBV) in carcinogenesis of hepatitis B surface antigen (HBsAg)‐negative, anti‐hepatitis C virus (anti‐HCV)‐positive hepatocellular carcinoma (HCC) remains unknown. To investigate the state of HBV DNA in such HCC, HBV DNA was examined by polymerase chain reaction (PCR) between HBV DNA and human Alu sequence (HBV‐Alu
S, Kawai   +4 more
openaire   +2 more sources

Enhancement of immune responses to an HBV DNA vaccine by electroporation

Vaccine, 2006
These studies document the ability of electroporation (EP)-based DNA vaccination to induce multi-specific CTL responses to hepatitis B virus (HBV) DNA vaccination in normal mice and marked immune responses to multivalent HBV DNA immunization in larger animal species.
A, Luxembourg   +4 more
openaire   +2 more sources

Mapping of 5′ Ends of Virion-Derived HBV DNA

Virology, 1992
Mapping of the 5' ends of virion-derived hepatitis B virus DNA molecules was carried out after cloning and sequencing linearized genomes made fully double stranded. Of five clones obtained, three of four minus strand termini mapped to the G in position 1826 and one to the T in position 1827.
J A, Saldanha   +3 more
openaire   +2 more sources

Treatment decisions based on HBV DNA

Journal of Viral Hepatitis
AbstractThe most common cause of hepatocellular carcinoma (HCC) worldwide is chronic hepatitis B virus (HBV) infection (CHB). Long‐term suppression of HBV replication by antiviral treatment reduces the risk of HCC and mortality. Nonetheless, only 2.2% of CHB patients globally received the treatment in 2019.
openaire   +2 more sources

Home - About - Disclaimer - Privacy